Terminology Service for NFDI4Health
HPV 16 E7:86-93 Peptide Vaccine
Go to external page
http://purl.obolibrary.org/obo/NCIT_C38761
A synthetic peptide vaccine consisting of amino acids 86 through 93 (TLGIVCPI) of the viral oncoprotein human papillomavirus (HPV) 16 E7. Vaccination with HPV-16 E7:86-93 peptide, which binds to HLA-A* 0201 molecule, may stimulate the host immune system to mount a cytotoxic T-lymphocyte (CTL) response against tumor cells positive for HPV-16 E7. [ ]
Term info
Label
HPV 16 E7:86-93 Peptide Vaccine
Synonyms
- E7(86-93) Lipopeptide
- HPV 16 E7:86-93 Peptide Vaccine
- HPV 16E7 86-93 Lipopeptide Vaccine
- HPV-16E7 (86-93)
Subsets
NCIT_C116978, NCIT_C128784, NCIT_C116977
Contributing Source
CTRP
Display Name
HPV 16 E7:86-93 Peptide Vaccine
Has Target
http://purl.obolibrary.org/obo/NCIT_C1179
Legacy Concept Name
HPV_16E7_86-93_Lipopeptide_Vaccine
PDQ Open Trial Search ID
43625
Preferred Name
HPV 16 E7:86-93 Peptide Vaccine
Semantic Type
Pharmacologic Substance, Amino Acid, Peptide, or Protein
UMLS CUI
C0879333
code
C38761
Term relations
Subclass of:
- Human Papilloma Virus Vaccine
- Antineoplastic Vaccine
- Chemical_Or_Drug_Has_Physiologic_Effect some T-Cell Activation
- Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue some Cytotoxic T-Lymphocyte
- Chemical_Or_Drug_Has_Mechanism_Of_Action some Antigen Sensitization
- Chemical_Or_Drug_Has_Physiologic_Effect some Immunopotentiation